Clinical Trials Directory

Trials / Terminated

TerminatedNCT01268072

A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease

A Prospective Observational Study to Evaluate Biomarkers in Acute Exacerbations in Chronic Obstructive Pulmonary Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
MedImmune LLC · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD

Detailed description

Identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD by evaluating longitudinal changes and the interrelationship of blood and sputum biomarkers with physiological endpoints and symptom measures in stable subjects with COPD likely to experience a future AECOPD, and in subjects during severe AECOPD.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2012-11-01
Completion
2013-01-01
First posted
2010-12-29
Last updated
2013-02-20

Locations

10 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01268072. Inclusion in this directory is not an endorsement.

A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease (NCT01268072) · Clinical Trials Directory